PubRank

J J Morton

Author PubWeight™ 273.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 TEMPERATURE EFFECT OF POPLITEAL VEIN LIGATION IN THROMBO-ANGIITIS OBLITERANS AND ARTERIOSCLEROSIS. Ann Surg 1928 28.36
2 THE EFFECT OF ROENTGEN RAYS ON THE RATE OF GROWTH OF SPONTANEOUS TUMORS IN MICE. J Exp Med 1915 13.91
3 Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998 7.51
4 THE LYMPHOCYTE IN NATURAL AND INDUCED RESISTANCE TO TRANSPLANTED CANCER : II. STUDIES IN LYMPHOID ACTIVITY. J Exp Med 1915 5.45
5 THE PRODUCTION OF LYMPHOMATOSIS IN MICE OF KNOWN GENETIC CONSTITUTION. Science 1938 4.28
6 Diverticulitis of the Colon. Ann Surg 1946 3.86
7 The Treatment of Ileus: As Indicated by Clinical Experience and Experimental Studies. Ann Surg 1932 3.37
8 SYMPATHETIC INHIBITION OF THE LARGE INTESTINE IN HIRSCHSPRUNG'S DISEASE. J Clin Invest 1930 3.29
9 Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 1984 3.13
10 Captopril in heart failure. A double blind controlled trial. Br Heart J 1984 2.85
11 INTERINNOMINO-ABDOMINAL (HINDQUARTER) AMPUTATION. Ann Surg 1942 2.81
12 Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J 1985 2.74
13 Evaluation of vulneray activity by an open wound procedure in rats. Arch Int Pharmacodyn Ther 1972 2.70
14 Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) 1985 2.14
15 An Evaluation of Pulmonary Embolism following Intravascular Venous Thrombosis. Ann Surg 1947 2.11
16 Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1999 2.10
17 Skin tumors following a single application of methylcholanthrene in C57 brown mice. Am J Pathol 1939 2.04
18 Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Heart J 1980 1.88
19 STUDIES ON THE ACTIVITY OF THE LUMBAR SYMPATHETIC NERVOUS SYSTEM. Ann Surg 1930 1.83
20 NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J 2006 1.81
21 Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001 1.77
22 Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis 2006 1.77
23 Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci (Lond) 1981 1.76
24 Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) 1982 1.76
25 Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients. Clin Pharmacol Ther 1980 1.64
26 Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension 1980 1.60
27 Chondrosarcoma. Ann Surg 1947 1.60
28 A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta 1980 1.58
29 OBSTRUCTIONS ABOUT THE MESENTERY IN INFANTS. Ann Surg 1936 1.54
30 Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 1999 1.47
31 Plasma endothelin in chronic heart failure. Circulation 1992 1.47
32 Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature 1981 1.42
33 Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Fail 2007 1.38
34 Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet 1979 1.37
35 A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states. J Endocrinol 1975 1.37
36 The Similarity in Effect of Experimental High Intestinal Obstruction and High Complete Intestinal Fistula. Ann Surg 1931 1.29
37 Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. Br J Clin Pharmacol 1976 1.22
38 Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol 1982 1.19
39 Measurement of plasma angiotensin II. Clin Sci (Lond) 1985 1.19
40 Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy. Lancet 1973 1.18
41 THE DIAGNOSIS AND TREATMENT OF ACUTE PANCREATITIS. Ann Surg 1940 1.17
42 Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988 1.16
43 Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res 1974 1.15
44 The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Res 1979 1.15
45 Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man. Br J Clin Pharmacol 1984 1.10
46 Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. J Hypertens Suppl 1983 1.09
47 PULSATING, BENIGN GIANT CELL TUMORS OF BONE. Ann Surg 1939 1.08
48 How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart 1999 1.08
49 STUDIES ON X-RAY EFFECTS : IV. DIRECT ACTION OF X-RAYS ON TRANSPLANTABLE CANCERS OF MICE. J Exp Med 1919 1.06
50 PHLEGMONOUS GASTRITIS: OF BACILLUS AEROGENES CAPSULATUS (B. WELCHII) ORIGIN. Ann Surg 1928 1.05
51 Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J 1975 1.05
52 Captopril, angiotensin II, and sodium in blood-pressure regulation. Lancet 1979 1.04
53 Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol 1981 1.03
54 THE QUANTITATIVE DETERMINATION OF VASOCONSTRICTOR SPASM AS A BASIS FOR THERAPY IN PERIPHERAL ARTERIAL DISEASES. Ann Surg 1932 1.02
55 Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. Lancet 1973 1.01
56 The Lymphocyte as a Factor in Natural and Induced Resistance to Transplanted Cancer. Proc Natl Acad Sci U S A 1915 1.01
57 Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995 1.01
58 Blood pressure and plasma angiotensin II concentration after renal artery constriction and angiotensin infusion in the dog. (5-Isoleucine)angiotensin II and its breakdown fragments in dog blood. Circ Res 1976 1.00
59 Early treatment with captopril after acute myocardial infarction. Br Heart J 1993 1.00
60 Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect. Clin Sci (Lond) 1980 1.00
61 Recurrent hyperkalaemia due to selective aldosterone deficiency: correction by angiotensin infusion. Br Med J 1973 0.99
62 Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure. Br Med J 1972 0.99
63 Relationship between plasma renin, renin-substrate, angiotensin II, aldosterone and electrolytes in normal pregnancy. J Clin Endocrinol Metab 1975 0.99
64 Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) 1981 0.98
65 Angiotensin II-induced thirst and vasopressin release in man. Clin Sci (Lond) 1985 0.98
66 Captopril in a hyponatraemic hypertensive: need for caution in initiating therapy. Lancet 1979 0.98
67 Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8), and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ Res 1976 0.97
68 Enalapril in the treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) 1983 0.97
69 SOME ANGIOSPASTIC SYNDROMES IN THE EXTREMITIES. Ann Surg 1931 0.97
70 N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart 2003 0.96
71 Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion. N Engl J Med 1981 0.96
72 ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation 1998 0.96
73 Angiotensin II and angiotensin III in rat blood. Circ Res 1976 0.96
74 Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. Circulation 1992 0.95
75 Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man. J Endocrinol 1977 0.94
76 Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess. Lancet 1974 0.94
77 Comparative evaluation of materials used for internal ureteral stents. J Endourol 1993 0.94
78 Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation 1996 0.94
79 Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 2000 0.94
80 Structural studies on the lipopolysaccharide of a rough strain of Escherichia coli. Eur J Biochem 1972 0.93
81 Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function. J Hypertens Suppl 1984 0.93
82 Amiloride in the treatment of primary hyperaldosteronism and essential hypertension. Clin Endocrinol (Oxf) 1977 0.92
83 Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 1992 0.92
84 The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme. Clin Sci (Lond) 1980 0.92
85 Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med 1973 0.91
86 Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) 1982 0.91
87 Hypertension and secondary hyperaldosteronism associated with a renin-secreting renal juxtaglomerular-cell tumour. Lancet 1973 0.91
88 Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult. J Cereb Blood Flow Metab 2000 0.90
89 Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997 0.89
90 Osmotic thirst and vasopressin release in humans: a double-blind crossover study. Am J Physiol 1985 0.89
91 A renal carcinoma secreting inactive renin. Clin Sci Mol Med Suppl 1978 0.89
92 Mechanism of renal hypertension. Lancet 1976 0.89
93 Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors. Lancet 1978 0.89
94 Angiotensin II activates Na+-H+ exchange and stimulates growth in cultured vascular smooth muscle cells. J Hypertens Suppl 1988 0.88
95 Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man. J Clin Endocrinol Metab 1988 0.88
96 Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition. Clin Exp Hypertens 1980 0.88
97 The role of plasma osmolality, angiotensin II and dopamine in vasopressin release in man. Clin Endocrinol (Oxf) 1985 0.88
98 Changes of vasopressin in hypertension: Cause or effect? Lancet 1976 0.88
99 Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 1994 0.88
100 Human fetal kidney morphometry during gestation and the relationship between weight, kidney morphometry and plasma active renin concentration at birth. Clin Sci (Lond) 1996 0.87
101 Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart 1999 0.87
102 Circulating endothelin in acute ischaemic syndromes. Br Heart J 1992 0.87
103 Rectal potential difference in the diagnosis of aldosterone excess. Gut 1975 0.87
104 Inverse relation of exchangeable sodium and blood pressure in hypertensive patients with renal artery stenosis. J Hypertens 1983 0.87
105 An NMR study of cerebral oedema and its biological correlates during withdrawal from alcohol. Alcohol Alcohol 1988 0.86
106 The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects. Clin Sci (Lond) 1980 0.86
107 Placement of large suprapubic tube using peel-away introducer. J Urol 1995 0.86
108 Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis. Hypertension 1999 0.86
109 Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int 1994 0.86
110 Body fluid changes, thirst and drinking in man during free access to water. Physiol Behav 1984 0.86
111 Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in man. Circ Res 1975 0.85
112 Captopril in heart failure: a double-blind study of the effects on renal function. J Cardiovasc Pharmacol 1986 0.85
113 Angiotensin converting enzyme inhibition reveals an important role for the renin system in the control of normal and high blood pressure in man. Clin Exp Hypertens A 1983 0.85
114 Transpulmonary angiotensin II formation in patients with chronic stable cor pulmonale. Am Rev Respir Dis 1987 0.85
115 Plasma levels of antidiuretic hormone in patients receiving prolonged lithium therapy. Br J Psychiatry 1977 0.85
116 Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension. Aust N Z J Med 1976 0.85
117 Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol 1998 0.85
118 Diurnal change in plasma atrial natriuretic peptide concentrations. Clin Sci (Lond) 1987 0.85
119 Plasma arginine vasopressin in the syndrome of antidiuretic hormone excess associated with bronchogenic carcinoma. Am J Med 1976 0.85
120 Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition. Clin Sci (Lond) 1979 0.84
121 Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor. Br J Clin Pharmacol 1979 0.84
122 The prevalence of hypertension in an unselected population, and the frequency of abnormalities of potassium, angiotensin II and aldosterone in hypertensive subjects. Acta Clin Belg 1974 0.84
123 Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension. Br J Clin Pharmacol 1979 0.84
124 Arginine vasopressin levels in cerebrospinal fluid in neurological disease. J Neurol Sci 1982 0.84
125 OBSERVATIONS ON SPINAL ANAESTHESIA. Ann Surg 1930 0.83
126 Angiotensin II suppression is a major factor permitting excretion of an acute sodium load in humans. Am J Physiol 1994 0.83
127 A study of the renin inhibitor H142 in man. J Hypertens 1985 0.83
128 T and B lymphocytes in patients with acute anterior uveitis and ankylosing spondylitis, and in their household contacts. Lancet 1979 0.83
129 A study of the renin-angiotensin system in the nephrotic syndrome. Nephron 1974 0.83
130 Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol. Br J Clin Pharmacol 1982 0.83
131 Angiotensin-induced myocardial necrosis and renal failure in the rabbit: distribution of lesions and severity in relation to plasma angiotensin II concentration and arterial pressure. Cardiovasc Res 1981 0.83
132 Total body and serum electrolyte composition in heart failure: the effects of captopril. Eur Heart J 1985 0.82
133 Raised plasma angiotensin II and aldosterone during dietary sodium restriction in man. Lancet 1972 0.82
134 Changes in urinary water and electrolyte excretion in sodium-loaded sheep in response to intravenous infusion of arginine vasopressin. Q J Exp Physiol Cogn Med Sci 1976 0.82
135 Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome. Am J Cardiol 1982 0.81
136 Response of aldosterone and blood pressure to angiotensin II infusion in anephric man. Effect of sodium deprivation. Circ Res 1976 0.81
137 The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney one-clip hypertensive rat. Clin Sci (Lond) 1983 0.81
138 Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci (Lond) 1990 0.81
139 Angiotensin II/aldosterone dose-response curves in the dog: effect of changes in sodium balance. Endocrinology 1978 0.81
140 The effect of oral prazosin on blood pressure and plasma concentrations of renin and angiotensin II in man. Clin Sci (Lond) 1981 0.81
141 Angiotensin II in essential hypertension. Br Med J 1977 0.81
142 Mineralocorticoid-induced blood pressure, electrolyte, and hormone changes, and reversal with spironolactone, in healthy men. Metabolism 1979 0.81
143 The renin-angiotensin system and total body sodium and potassium in hypertensive women taking oestrogen-progestagen oral contraceptives. Clin Endocrinol (Oxf) 1983 0.81
144 The role of angiotensin II in the development of peripheral vasoconstriction during open-heart surgery. Am Heart J 1980 0.80
145 Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery. Hypertension 1981 0.80
146 NT-proBNP does not rise on acute ascent to high altitude. High Alt Med Biol 2008 0.80
147 A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man. Br J Clin Pharmacol 1985 0.79
148 Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure. J Am Coll Cardiol 1999 0.79
149 Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man. Clin Nephrol 1975 0.79
150 Significance of renin and angiotensin in hypertension. Cardiovasc Clin 1978 0.79
151 Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance. Am J Cardiol 1982 0.79
152 des-Asp-angiotensin I: its identification in rat blood and confirmation as a substrate for converting enzyme. Endocrinology 1981 0.79
153 The effect of sodium deprivation and of angiotensin II infusion on the peripheral plasma concentrations of 18-hydroxycorticosterone, aldosterone and other corticosteroids in man. J Steroid Biochem 1977 0.79
154 Specific binding of atrial natriuretic peptide increases cyclic GMP levels in human astrocytoma cells. J Endocrinol 1988 0.79
155 ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects. Am Heart J 2001 0.79
156 Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock. Circ Res 1977 0.79
157 Plasma concentrations of inactive renin in adult life are related to indicators of foetal growth. J Hypertens 1996 0.79
158 Arterial angiotensin II and venous immunoreactive material before and during angiotensin infusion in man. Clin Sci 1972 0.79
159 Studies on aldosterone responsiveness to angiotensin II during clinical variations in calcium metabolism in normal man. Clin Sci (Lond) 1982 0.79
160 Evidence in humans for a postsynaptic interaction between noradrenaline and angiotensin II with regard to systolic but not diastolic blood pressure. J Hypertens 1987 0.79
161 Improved technique for transduodenal pancreas transplant biopsy. Transplantation 1994 0.79
162 The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats. J Hypertens 1995 0.78
163 Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II. J Hum Hypertens 1995 0.78
164 Antidiuretic hormone excretion at high altitude. Aviat Space Environ Med 1981 0.78
165 Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. J Hypertens 2000 0.78
166 Lithium induced nephrogenic diabetes insipidus: changes in plasma vasopressin and angiotensin II. Clin Nephrol 1975 0.78
167 Circulating endothelin is not extracted by the pulmonary circulation in man. Chest 1992 0.78
168 The pathophysiology of renovascular hypertension. J Hypertens Suppl 1986 0.78
169 Is the 'sodium index' a useful way of expressing clinical plasma renin, angiotensin and aldosterone values? Clin Endocrinol (Oxf) 1978 0.78
170 Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1994 0.78
171 Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction. J Cardiovasc Pharmacol 1987 0.78
172 Antidiuretic hormone in bronchogenic carcinoma. Clin Endocrinol (Oxf) 1978 0.78
173 The myth of idiopathic hyperaldosteronism. Lancet 1981 0.78
174 Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction. Cardiovasc Res 1998 0.78
175 Studies of the renin-angiotension-aldosterone system, cortisol, DOC, and ADH in normal and hypertensive pregnancy. Perspect Nephrol Hypertens 1976 0.78
176 Angiotensin II in human cerebrospinal fluid may be an immunoassay artifact. Clin Sci (Lond) 1980 0.78
177 Relationship between plasma aldosterone and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essential hypertension. J Clin Endocrinol Metab 1984 0.78
178 Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans. J Cardiovasc Pharmacol 1982 0.78
179 Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. Br J Clin Pharmacol 2001 0.77
180 Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition. Am J Med 1984 0.77
181 Peptide inhibitors of renin. Clin Exp Hypertens A 1983 0.77
182 The adrenal cortex and hypertension: some observations on a possible role for mineralocorticoids other than aldosterone. J Steroid Biochem 1977 0.77
183 Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats. Clin Sci (Lond) 1982 0.77
184 Demeclocycline in the treatment of the syndrome of inappropriate antidiuretic hormone release: with measurement of plasma ADH. Postgrad Med J 1978 0.77
185 The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Aust N Z J Med 1976 0.77
186 The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Prog Biochem Pharmacol 1976 0.77
187 A case of hypopituitarism with diabetes insipidus and loss of thirst. Role of antidiuretic hormone and angiotensin II in the control of urine flow and osmolality. J Clin Endocrinol Metab 1975 0.77
188 Structural and functional assessment of small arteries in patients with chronic heart failure. Clin Sci (Lond) 1999 0.77
189 Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertension. Hypertension 1984 0.77
190 Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery. Heart 2006 0.77
191 Relationship between exchangeable sodium and blood pressure in different forms of hypertension in man. Clin Sci (Lond) 1979 0.77
192 Specific binding of atrial natriuretic peptide to rat mesenteric artery: effect of calcium and 5-guanylylimidodiphosphate. Clin Sci (Lond) 1987 0.77
193 Angiotensin II, vascular structure and blood pressure. Kidney Int Suppl 1992 0.76
194 N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation. Heart 2006 0.76
195 Effects of the renin inhibitor H77 on angiotensin II, arterial pressure and cardiac function in conscious dogs: comparison with captopril. J Hypertens Suppl 1989 0.76
196 Invasive cytomegalovirus infection in a renal transplant ureter after combined pancreas-kidney transplantation: an unusual cause of renal allograft dysfunction. J Urol 1994 0.76
197 New inhibitors of human renin tested in vitro and in vivo in the anaesthetized baboon. J Hypertens 1983 0.76
198 Proceedings: Application of a sensitive radioimmunoassay for plasma arginine vasopressin to pathological conditions in man. Clin Sci Mol Med 1974 0.76
199 Fluid balance, vasopressin and withdrawal symptoms during detoxification from alcohol. Drug Alcohol Depend 1989 0.76
200 Does vasopressin play a role in the pathogenesis of hypertension? Clin Sci (Lond) 1981 0.76
201 Atrial natriuretic factor and changes in the aldosterone response to angiotensin II in sodium depleted dogs. Clin Exp Hypertens 1993 0.76
202 Neuroendocrine activation and markers of early reperfusion in the acute phase of myocardial infarction. Eur Heart J 1993 0.76
203 Neuroendocrine activation in acute myocardial infarction. J Cardiovasc Pharmacol 1987 0.76
204 The clinical value of renin and angiotensin estimations. Kidney Int Suppl 1975 0.76
205 Relation of blood pressure with body and plasma electrolytes in Conn's syndrome. J Hypertens 1983 0.75
206 Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man. Cardiovasc Drugs Ther 1987 0.75
207 Measurement of brain natriuretic peptide. Lancet 1996 0.75
208 Response of antidiuretic hormone to chlorpropamide. Br Med J 1980 0.75
209 Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin. Heart 2003 0.75
210 Calcium and blood pressure regulation in normal and hypertensive subjects. Hypertension 1983 0.75
211 THE ETIOLOGY OF CANCER IN THE LIGHT OF OUR PRESENT KNOWLEDGE. Ann Surg 1937 0.75
212 Chronic Constrictive Pericarditis. Successful Partial Resection of the Pericardium in Two Patients. Trans Am Clin Climatol Assoc 1938 0.75
213 Treatment of recurrent vesicourethral anastomotic stricture after radical prostatectomy with endourethroplasty. Urology 1996 0.75
214 Potassium in the syndrome of inappropriate antidiuretic hormone secretion. Postgrad Med J 1979 0.75
215 Hormonal and blood pressure changes during converting enzyme inhibition by teprotide. Postgrad Med J 1981 0.75
216 Renin and blood pressure. Biochem Soc Trans 1984 0.75
217 Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium. J Hypertens 1983 0.75
218 The measurement of arginine vasopressin in human plasma by radioimmunoassay. Clin Sci 1973 0.75
219 Contraceptive steroids and hypertension. J Steroid Biochem 1975 0.75
220 The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J Steroid Biochem Mol Biol 1993 0.75
221 Vasopressin in hypertension. Clin Endocrinol (Oxf) 1981 0.75
222 Vasopressin and hypertension in man. J Cardiovasc Pharmacol 1986 0.75
223 Effect of changes in sodium balance on potassium/aldosterone dose-response curves in the dog. Clin Sci (Lond) 1982 0.75
224 Prolonged infusion of norepinephrine in the conscious dog: effects on blood pressure, heart rate, renin, angiotensin II, and aldosterone. J Cardiovasc Pharmacol 1982 0.75
225 Adrenergic activity and aldosterone regulation: no evidence for an alpha-1 adrenoceptor-mediated influence in normal subjects. Clin Endocrinol (Oxf) 1986 0.75
226 Inhibitors of rat renin and their use in experimental hypertension. J Hypertens Suppl 1989 0.75
227 Ligation of the Abdominal Aorta for Aneurysm: Complicated by Rupture into the Retroperitoneal Space. Ann Surg 1944 0.75
228 The effect of chronic prazosin therapy on the response of the renin-angiotensin system in patients with essential hypertension. J Hum Hypertens 1987 0.75
229 Vascular hypertrophy and hypertension: a role for growth factors? Acta Physiol Scand Suppl 1988 0.75
230 Severe hypotension with bradycardia during renin inhibition with H142 in sodium deplete man. J Hum Hypertens 1989 0.75
231 Angiotensin, aldosterone and DOC in hypertensive disease of pregnancy. Scott Med J 1973 0.75
232 Antidiuretic hormone immunoactivity in tumour tissue from patients with bronchogenic carcinoma: with and without hyponatraemia. Clin Endocrinol (Oxf) 1980 0.75
233 Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol. Clin Sci Mol Med Suppl 1976 0.75
234 The role of sodium status in the control of blood pressure: studies in anephric patients and in renal hypertensives. Acta Clin Belg 1977 0.75
235 The effects of vasopressin on renal sodium excretion in pigs given intravascular hypertonic salt loads. Q J Exp Physiol Cogn Med Sci 1977 0.75
236 Effect of alpha-adrenergic blockade on pituitary hormonal responses to insulin-induced hypoglycemia in humans. Acta Endocrinol (Copenh) 1991 0.75
237 The interaction of sodium and potassium status, of ACTH and of angiotensin II in the control of corticosteroid secretion. J Steroid Biochem 1979 0.75
238 Haemodynamic effects of angiotensin converting enzyme inhibition after cardiopulmonary bypass in dogs. Cardiovasc Res 1980 0.75
239 Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) 1982 0.75
240 Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone. J Cardiovasc Pharmacol 1985 0.75
241 An altered relation between arterial pressure and plasma angiotensin II concentration resulting from prolonged infusion of angiotensin II. Clin Sci Mol Med Suppl 1978 0.75
242 Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function. Am J Cardiol 1987 0.75
243 The possible relationship between the affinity of arginine-vasopressin antibodies and the degree of polyuria and polydipsia in actively immunized rabbits. J Endocrinol 1972 0.75
244 Platelet cytosolic free calcium in essential hypertension: responses to vasopressin. Clin Sci (Lond) 1989 0.75
245 Effect of acute and chronic captopril infusion on blood pressure in the two-kidney, one clip hypertensive rat. J Hypertens 1985 0.75
246 Disparity between studies of the stability of BNP in blood: comparison of endogenous and exogenous peptide. Heart 1999 0.75
247 The vasodepressor action of prostacyclin (PGI2) and its effect on plasma angiotensin II and vasopressin in unanaesthetized normotensive and hypertensive rats. Clin Exp Hypertens 1979 0.75
248 Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios. J Hum Hypertens 1995 0.75
249 Measurement of plasma renin concentration and angiotensin II in peripheral and renal venous plasma in the management of renovascular hypertension. Contrib Nephrol 1976 0.75
250 Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition? J Endocrinol 1979 0.75
251 Isolated analdosteronism with deficiency of renin and angiotensin. Clin Sci 1972 0.75
252 The interaction between noradrenaline and angiotensin II in man: evidence for a postsynaptic and against a presynaptic interaction. J Hypertens Suppl 1987 0.75
253 Enhanced diurnal variation of blood pressure in the renal hypertensive rat: effect of angiotensin II suppression. Clin Sci (Lond) 1987 0.75
254 Severe hypertension with absent secondary sex characteristics due to partial deficiency of steroid 17 alpha-hydroxylase activity. J Hum Hypertens 1987 0.75
255 Changes in active and inactive renin and in angiotensin II across the kidney in essential hypertension and renal artery stenosis. J Hypertens 1984 0.75
256 Renal hypertension: role for renin. Postgrad Med J 1977 0.75
257 Twice-daily low-dose captopril in diuretic-treated hypertensives. J Hum Hypertens 1989 0.75
258 Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site. J Pept Res 1997 0.75
259 Relationship of renin, angiotensin II and atrial natriuretic factor to clinical status in the early post-infarct period in patients with left ventricular dysfunction. Eur Heart J 1994 0.75
260 The relationship between the plasma concentrations of renin and angiotensin with total exchangeable sodium in hypertension. Verh Dtsch Ges Inn Med 1974 0.75
261 Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension. Am Heart J 1977 0.75
262 The effect of sodium balance on the aldosterone and pressor dose-response curves to angiotensin II in the dog [proceedings]. J Physiol 1977 0.75
263 Pancreatic and pituitary hormonal responses to insulin-induced hypoglycaemia during muscarinic cholinergic blockade in man. Eur J Clin Invest 1992 0.75
264 Renal hypertension. The renin system in hypertension with unilateral renal artery stenosis. Przegl Lek 1985 0.75
265 SUBLINGUAL FIBROMA. Ann Surg 1924 0.75
266 Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome. Acta Neurol Scand 1993 0.75
267 Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects. Clin Endocrinol (Oxf) 1979 0.75
268 Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism. Hypertension 1981 0.75
269 Are idiopathic hyperaldosteronism and low-renin hypertension variants of essential hypertension? Ann Clin Biochem 1979 0.75
270 The renin-angiotensin system and aldosterone in hypertension: a brief review of some aspects. Int J Obes 1981 0.75
271 The effect of angiotensin II infusion on plasma corticosteroid concentrations in normal man. J Steroid Biochem 1976 0.75
272 Inactive renin in human plasma. Lancet 1976 0.75
273 The interaction of ACTH and angiotensin II in the control of corticosteroid plasma concentration in man. J Steroid Biochem 1979 0.75
274 Can angiotensin II cause renal hypertension when its plasma concentration is normal? Contrib Nephrol 1977 0.75
275 CIRCULATORY FACTORS INFLUENCING NORMAL OSTEOGENESIS. Ann Surg 1927 0.75
276 Renal secretion of inactive renin and extraction of angiotensin II in renal artery stenosis in man: factors determining renal vein renin ratio. J Hypertens Suppl 1984 0.75
277 Role of renin as a blood-borne hormone tested by infusion of renin inhibitor (H.77). Kidney Int Suppl 1988 0.75
278 Investigation of adrenergic beta-receptor blockade and mescaline-induced bradycardia. J Pharm Sci 1969 0.75
279 Inter-relationships between plasma angiotensin II, arterial pressure, aldosterone and exchangeable sodium in normotensive and hypertensive man. J Steroid Biochem 1975 0.75
280 Chronic captopril infusion in two-kidney, one clip rats with normal plasma renin concentration. J Hypertens 1984 0.75
281 Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man. J Clin Hypertens 1986 0.75
282 No acute additive effect of losartan in a patient already on an ACE inhibitor for heart failure. J Hum Hypertens 1999 0.75
283 Inactive renin in human plasma. Lancet 1976 0.75
284 Importance of RAA system and the treatment of patients with ACE inhibition after myocardial infarction. Angiology 1991 0.75
285 A novel extraction method for plasma vasopressin and its application in a radioimmunoassay. J Endocrinol 1978 0.75
286 Renin, angiotensin II and III in acute renal failure: note on the measurement of of angiotensin II and III in rat blood. Kidney Int Suppl 1976 0.75
287 Amiloride in the treatment of primary hyperaldosteronism and essential hypertension. Clin Exp Pharmacol Physiol Suppl 1978 0.75
288 Factors affecting renal vein renin ratio in renal artery stenosis. Secretion of inactive renin. Nephron 1986 0.75
289 A highly sensitive cytochemical bioassay for plasma angiotensin II. Clin Endocrinol (Oxf) 1983 0.75
290 Clinical and biochemical effects of the renin inhibitor H142 in humans. J Cardiovasc Pharmacol 1987 0.75
291 The relative potency of amiloride and spironolactone in bendrofluazide-treated hypertensive patients [proceedings]. Br J Clin Pharmacol 1978 0.75
292 An inactive renin in human plasma. Circ Res 1977 0.75
293 Reduction of blood pressure in man with H-142, a potent new renin inhibitor. Lancet 1984 0.75